{
    "eid": "2-s2.0-85119103966",
    "title": "A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age",
    "cover-date": "2022-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Immunology and Microbiology (all)",
            "@code": "2400",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Veterinary (all)",
            "@code": "3400",
            "@abbrev": "VETE"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Genetically-inactivated",
        "Immunogenicity",
        "Low-dose",
        "Non-pregnant",
        "Pertussis",
        "Safety"
    ],
    "authors": [
        "Kulkanya Chokephaibulkit",
        "Thanyawee Puthanakit",
        "Niranjan Bhat",
        "Souad Mansouri",
        "Yuxiao Tang",
        "Keswadee Lapphra",
        "Supattra Rungmaitree",
        "Suvaporn Anugulruengkitt",
        "Watsamon Jantarabenjakul",
        "Indah Andi-Lolo",
        "Renee Holt",
        "Librada Fortuna",
        "Chawanee Kerdsomboon",
        "Pailinrut Chinwangso",
        "Ladda Suwitruengrit",
        "Anita H.J. van den Biggelaar",
        "Simonetta Viviani",
        "Hong Thai Pham",
        "Bruce L. Innis"
    ],
    "citedby-count": 1,
    "ref-count": 38,
    "ref-list": [
        "Global, regional, and national causes of under-5 mortality in 2000\u201315: an updated systematic analysis with implications for the Sustainable Development Goals",
        "Assessing the evidence for maternal pertussis immunization: a report from the Bill & Melinda Gates Foundation Symposium on pertussis infant disease burden in low- and lower-middle-income countries",
        "Pertussis across the globe: recent epidemiologic trends from 2000 to 2013",
        "An update of the global burden of pertussis in children younger than 5 years: a modelling study",
        "Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update",
        "Effectiveness of maternal pertussis vaccination in England: an observational study",
        "Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction",
        "Pertussis vaccines: WHO position paper - September 2015",
        "A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group",
        "A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial",
        "Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial",
        "Boosting teenagers with acellular pertussis vaccines containing recombinant or chemically inactivated pertussis toxin: a randomized clinical trial",
        "Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aP(gen) or combined TdaP(gen) vaccines",
        "Maternal vaccination with a monocomponent pertussis toxoid vaccine is sufficient to protect infants in a baboon model of whooping cough",
        "Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults",
        "Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19\u201364 years of age",
        "Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review",
        "The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies",
        "Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator",
        "Physico-chemical analysis of Bordetella pertussis antigens",
        "Diphtheria vaccine: WHO position paper \u2013 August 2017",
        "Tetanus vaccines: WHO position paper \u2013 February 2017",
        "Incidence of tetanus and diphtheria in relation to adult vaccination schedules",
        "Immunization policy development in Thailand: the role of the Advisory Committee on Immunization Practice",
        "Seroprevalence of antibodies to pertussis toxin among different age groups in Thailand after 37 years of universal whole-cell pertussis vaccination",
        "Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women",
        "Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis",
        "Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants <2 months of age: a case-control evaluation",
        "Maternal vaccination in Argentina: Tdap vaccine effectiveness during pregnancy in preventing pertussis in infants less than 2 months of age",
        "Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections",
        "Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study",
        "Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen) vaccine for immunization of adolescents and adults in Thailand"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "119943544",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/119943544",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Washington",
            "@id": "115517645",
            "affilname": "PATH",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/115517645",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "BIOPHICS",
        "Faculty of Medicine Siriraj Hospital, Mahidol University and Center of Excellence in Pediatric Infectious Diseases and Vaccines",
        "Bill & Melinda Gates Foundation",
        "Chulalongkorn University"
    ]
}